Vaccine effectiveness of the mRNA-1273 3-dose primary series against COVID-19 in an immunocompromised population: A prospective observational cohort study.

"appendix a supplementary data the following are the supplementary data to this article: supplementary data 1 data availability the authors do not have permission to share data."

"Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: JHK, LSS, LQ, BKA, YL, JET, GSL, AF, SQ, and HFT are employees of Kaiser Permanente Southern California, which has been contracted by Moderna to conduct this study. KJB is an adjunct investigator at Kaiser Permanente Southern California. YT was an employee of Kaiser Permanente Southern California at the time of preparing the manuscript. CAT was an employee of and a shareholder in Moderna Inc. at the time of these analyses; CAT is currently an employee of AstraZeneca. JHK received funding from GlaxoSmithKline unrelated to this manuscript. LSS received funding from GlaxoSmithKline and Dynavax unrelated to this manuscript. LQ received funding from GlaxoSmithKline and Dynavax unrelated to this manuscript. BKA received funding from GlaxoSmithKline, Dynavax, Genentech, and Pfizer unrelated to this manuscript. YL received funding from GlaxoSmithKline, and Pfizer unrelated to this manuscript. JET received funding from Pfizer unrelated to this manuscript. GSL received funding from GlaxoSmithKline unrelated to this manuscript. AF received funding from Pfizer, GlaxoSmithKline, and Gilead unrelated to this manuscript. KJB received funding from GlaxoSmithKline, Dynavax, Pfizer, and Gilead unrelated to this manuscript. SQ received funding from Dynavax unrelate.d to this manuscript. YT received funding from GlaxoSmithKline unrelated to this manuscript. HFT received funding from GlaxoSmithKline unrelated to this manuscript; HFT also served in advisory boards for Janssen and Pfizer."

"Funding This work was supported by Moderna, Inc."